Učitavanje...
Immune checkpoint inhibitor-associated gastrointestinal and hepatic adverse events and their management
BACKGROUND: Drug-induced colitis is a known complication of therapies that alter the immune balance, damage the intestinal barrier or disturb intestinal microbiota. Immune checkpoint inhibitors (ICI) directed against cancer cells may result in activated T lymphocyte-induced immune-related adverse ev...
Spremljeno u:
| Izdano u: | Therap Adv Gastroenterol |
|---|---|
| Glavni autori: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6831976/ https://ncbi.nlm.nih.gov/pubmed/31723355 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756284819884196 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|